Avalo Therapeutics (AVTX) Times Interest Earned (2014 - 2015)

Avalo Therapeutics (AVTX) has 13 years of Times Interest Earned data on file, last reported at -$0.88 in Q1 2026.

• Quarterly Times Interest Earned rose 99.64% year-over-year to -$0.88 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.33 (up 98.46% YoY) and the FY2025 annual result came in at -$1.83, down 75.15% from the prior year.
• Times Interest Earned improved to -$0.88 in Q1 2026, from -$2193.6 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $6.84 in Q3 2022 to a low of -$2193.6 in Q4 2025.
• A 5-year average of -$245.04 and a median of -$13.12 in 2022 frame the typical range for Times Interest Earned.
• Annual changes were most pronounced in 2022 — Times Interest Earned surged 248.12% — and 2024, when it slumped 18358.37%.
• Tracing AVTX's Times Interest Earned over 5 years: stood at -$13.12 in 2022, then jumped by 134.36% to $4.51 in 2023, then plunged by 5021.95% to -$221.85 in 2024, then tumbled by 888.76% to -$2193.6 in 2025, then jumped by 99.96% to -$0.88 in 2026.
• The last three Times Interest Earned figures came in at -$0.88 (Q1 2026), -$2193.6 (Q4 2025), and -$325.39 (Q3 2025), per Business Quant data.